26.9137 USD
-0.08 (-0.28%)
MTBCP gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. While MTBCP seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, MTBCP is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
MTBCP had negative earnings in the past year.
MTBCP had a positive operating cash flow in the past year.
1.2 Ratios
MTBCP has negative profitability rations, so we won't be analyzing them here.
MTBCP's Return On Invested Capital of 4.81% is amongst the best of the industry. MTBCP outperforms 84.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | 4.81% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Operating Margin value of 3.77%, MTBCP is doing good in the industry, outperforming 73.33% of the companies in the same industry.
Looking at the Gross Margin, with a value of 38.04%, MTBCP is doing worse than 66.67% of the companies in the same industry.
MTBCP's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.77% | ||
| PM (TTM) | N/A | ||
| GM | 38.04% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-3.59%
2. Health
2.1 Basic Checks
MTBCP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, MTBCP has more shares outstanding
MTBCP has a worse debt/assets ratio than last year.
2.2 Solvency
MTBCP has an Altman-Z score of 9.66. This indicates that MTBCP is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 9.66, MTBCP belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
MTBCP has a debt to FCF ratio of 0.06. This is a very positive value and a sign of high solvency as it would only need 0.06 years to pay back of all of its debts.
MTBCP has a better Debt to FCF ratio (0.06) than 82.22% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that MTBCP is not too dependend on debt financing.
MTBCP has a better Debt to Equity ratio (0.00) than 64.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.06 | ||
| Altman-Z | 9.66 |
ROIC/WACC0.6
WACC8.03%
2.3 Liquidity
A Current Ratio of 1.21 indicates that MTBCP should not have too much problems paying its short term obligations.
MTBCP has a Current ratio of 1.21. This is in the lower half of the industry: MTBCP underperforms 73.33% of its industry peers.
MTBCP has a Quick Ratio of 1.19. This is a normal value and indicates that MTBCP is financially healthy and should not expect problems in meeting its short term obligations.
MTBCP has a worse Quick ratio (1.19) than 71.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.19 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 56.73% over the past year.
MTBCP shows a small growth in Revenue. In the last year, the Revenue has grown by 7.14%.
MTBCP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 41.63% yearly.
EPS 1Y (TTM)56.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
Revenue 1Y (TTM)7.14%
Revenue growth 3Y40.35%
Revenue growth 5Y41.63%
Sales Q2Q%-11.96%
3.2 Future
The Earnings Per Share is expected to grow by 6.25% on average over the next years.
The Revenue is expected to grow by 2.57% on average over the next years.
EPS Next Y13.69%
EPS Next 2Y7.89%
EPS Next 3Y16.8%
EPS Next 5Y6.25%
Revenue Next Year0.64%
Revenue Next 2Y1.19%
Revenue Next 3Y3.72%
Revenue Next 5Y2.57%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
MTBCP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MTBCP. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MTBCP indicates a rather cheap valuation: MTBCP is cheaper than 84.44% of the companies listed in the same industry.
MTBCP's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. MTBCP is cheaper than 71.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 46.5 | ||
| EV/EBITDA | 23.41 |
4.3 Compensation for Growth
A more expensive valuation may be justified as MTBCP's earnings are expected to grow with 16.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.89%
EPS Next 3Y16.8%
5. Dividend
5.1 Amount
MTBCP does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:MTBCP (1/9/2023, 8:23:58 PM)
26.9137
-0.08 (-0.28%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap409.63M
Revenue(TTM)143.75M
Net Income(TTM)-6.85M
Analysts83.64
Price Target76.1 (182.76%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-220.54%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.24%
Min EPS beat(2)4.61%
Max EPS beat(2)61.87%
EPS beat(4)4
Avg EPS beat(4)48.06%
Min EPS beat(4)4.61%
Max EPS beat(4)94.23%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.73%
Min Revenue beat(2)-3.14%
Max Revenue beat(2)-2.32%
Revenue beat(4)1
Avg Revenue beat(4)-1.01%
Min Revenue beat(4)-3.14%
Max Revenue beat(4)2.51%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.43%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.17%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 2.85 | ||
| P/FCF | 46.5 | ||
| P/OCF | 19.3 | ||
| P/B | 3.98 | ||
| P/tB | 34.48 | ||
| EV/EBITDA | 23.41 |
EPS(TTM)-0.45
EYN/A
EPS(NY)-0.66
Fwd EYN/A
FCF(TTM)0.58
FCFY2.15%
OCF(TTM)1.39
OCFY5.18%
SpS9.44
BVpS6.76
TBVpS0.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | 4.81% | ||
| ROICexc | 4.99% | ||
| ROICexgc | 43.34% | ||
| OM | 3.77% | ||
| PM (TTM) | N/A | ||
| GM | 38.04% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-3.59%
F-Score4
Asset Turnover1.1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.06 | ||
| Debt/EBITDA | 0.03 | ||
| Cap/Depr | 103.98% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.19 | ||
| Altman-Z | 9.66 |
F-Score4
WACC8.03%
ROIC/WACC0.6
Cap/Depr(3y)81.08%
Cap/Depr(5y)58.98%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)56.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
EPS Next Y13.69%
EPS Next 2Y7.89%
EPS Next 3Y16.8%
EPS Next 5Y6.25%
Revenue 1Y (TTM)7.14%
Revenue growth 3Y40.35%
Revenue growth 5Y41.63%
Sales Q2Q%-11.96%
Revenue Next Year0.64%
Revenue Next 2Y1.19%
Revenue Next 3Y3.72%
Revenue Next 5Y2.57%
EBIT growth 1Y261.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1308.1%
EBIT Next 3Y177.57%
EBIT Next 5Y93.09%
FCF growth 1Y213.67%
FCF growth 3Y-21.74%
FCF growth 5YN/A
OCF growth 1Y1553.9%
OCF growth 3Y25.1%
OCF growth 5YN/A
CARECLOUD INC - MTBC 11 PERP / MTBCP FAQ
What is the ChartMill fundamental rating of CARECLOUD INC - MTBC 11 PERP (MTBCP) stock?
ChartMill assigns a fundamental rating of 3 / 10 to MTBCP.
What is the valuation status for MTBCP stock?
ChartMill assigns a valuation rating of 1 / 10 to CARECLOUD INC - MTBC 11 PERP (MTBCP). This can be considered as Overvalued.
Can you provide the profitability details for CARECLOUD INC - MTBC 11 PERP?
CARECLOUD INC - MTBC 11 PERP (MTBCP) has a profitability rating of 1 / 10.
How sustainable is the dividend of CARECLOUD INC - MTBC 11 PERP (MTBCP) stock?
The dividend rating of CARECLOUD INC - MTBC 11 PERP (MTBCP) is 0 / 10 and the dividend payout ratio is -220.54%.